Paid Clinical Trials in Richmond, VA
As of September 2026, 580 paid clinical trials are recruiting in Richmond, Virginia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Richmond offers studies at sites including Virginia Commonwealth University for conditions such as Heart Failure, Obesity, Breast Cancer, Acute Myeloid Leukemia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Richmond
Trials by drug in Richmond
Filter results
Newly added in Richmond
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Open-label Feasibility Trial of HD-tDCS During Cognitive Behavioral Therapy for Cocaine Use Disorder
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
524 clinical trials
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Study of DONQ52 in Active Celiac Disease
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Top Research Study Locations in Richmond
Researchers run research studies in Richmond, VA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Virginia Commonwealth University | Heart Failure, Myotonic Dystrophy 1, Violence | 157 |
| VCU Massey Comprehensive Cancer Center | Malignant Solid Neoplasm, Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8 | 107 |
| VCU Massey Cancer Center at Stony Point | Anatomic Stage II Breast Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8, Lung Non-Small Cell Carcinoma | 51 |
| Virginia Cancer Institute | Anatomic Stage II Breast Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Anatomic Stage I Breast Cancer AJCC v8 | 23 |
| Bon Secours Saint Mary's Hospital | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 22 |
| Bon Secours Cancer Institute at Reynolds Crossing | Stage IVA Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8 | 17 |
| Clinical Research Partners, LLC | Overweight, Pneumococcal Disease, Adult | 14 |
| Bon Secours Richmond Community Hospital | Breast Cancer, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 11 |
| GSK Investigational Site | Chickenpox, Colonic Neoplasms, Influenza, Human | 9 |
| VCU Medical Center | Acute Decompensated Heart Failure, Chemotherapy Induced Peripheral Neuropathy (CIPN), Chronic Thromboembolic Pulmonary Hypertension | 9 |
| Virginia Commonwealth University Massey Cancer Center | B-cell Malignancy, Cervical Cancer, Chemotherapy-induced Peripheral Neuropathy | 9 |
| Richmond VA Medical Center | Colorectal Neoplasms, Dementia Alzheimer Type, Dementia Associated With Cerebrovascular Disease | 7 |
| Virginia Commonwealth University Medical Center | Adolescent - Emotional Problem, Bipolar Disorder, Bipolar I Disorder | 7 |
| Hunter Holmes McGuire VA Medical Center, Richmond, VA | Acute Kidney Injury, Atherosclerosis, Cardiovascular Disease | 6 |
| Richmond VA Medical Center, Richmond, VA | Alcohol Use Disorder (AUD), Cirrhosis, Epilepsy | 6 |
| OvationLab | Gastrointestinal, Biological Aging, Detoxification | 5 |
| Virginia Commonwealth University/Massey Cancer Center | Stage IVB Prostate Cancer AJCC v8, Breast Carcinoma, Castration Levels of Testosterone | 5 |
| VCU Massey Cancer Center | Cutaneous Melanoma, Stage II, Metastatic Head-and-neck Squamous-cell Carcinoma, Non-small Cell Lung Cancer | 5 |
| Clinical Trial Site | Advanced Hepatocellular Carcinoma, High Cardiovascular Risk, High Risk Cardiovascular Disease | 4 |
| Children's Hospital of Richmond at VCU | Becker Muscular Dystrophy, Cardiac Arrest, Cardiac Arrest (CA) | 4 |
| Henrico Doctor's Hospital | Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma | 4 |
| National Clin Res Inc. | Obesity, Overweight, Diabetes Mellitus | 4 |
| Pulmonary Associates of Richmond, Inc. | Interstitial Lung Disease, Progressive Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis | 4 |
| Chippenham Hospital | Hypertension, Lumbar Spinal Stenosis, Percutaneous Coronary Intervention | 3 |
| Dominion Medical Associates | Cardiovascular Disease and Lipoprotein(a), Cardiovascular Risk, Hypercholesterolaemia | 3 |
Active & Upcoming Studies in Richmond (2026)
Recruiting trials in Richmond grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (208 active studies)
- A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma · Phase 3 · AbbVie
- Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening · Virginia Commonwealth University
Cardiovascular (43 active studies)
- CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA) · VA Office of Research and Development
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Diabetes & metabolic (26 active studies)
- Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS) · Phase 3 · Eli Lilly and Company
- A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide · Phase 3 · Novo Nordisk A/S
Neurology & pain (18 active studies)
- Bedside Cranial Ultrasound for Risk-Stratified Imaging in Pediatric Acute Brain Injury · Virginia Commonwealth University
- Transcranial Doppler Evaluation After Endovascular Thrombectomy for Acute Ischemic Stroke (PRECISE-TCD) · Virginia Commonwealth University
Mental health & behavior (15 active studies)
- QAIAx (AIhealth4U) - AI Smart Health Cities: Microcity Enclave Program (Quantum AI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360) · Veterans Recovery Network Inc.
- Enhancing Addiction Treatment Through Psychoeducation · Virginia Commonwealth University
Vaccines (8 active studies)
- A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age · Phase 3 · GlaxoSmithKline
- A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age · Phase 2 · ModernaTX, Inc.
Pediatric (5 active studies)
- Children's Bipolar Network Treatment Trial I · University of California, Los Angeles
- Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS · Phase 2, Phase 3 · Nationwide Children's Hospital
HIV / STI (4 active studies)
- A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV · Phase 2 · Naga P. Chalasani
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection · Phase 1 · GigaGen, Inc.
Eye & vision (1 active study)
Common conditions studied in Richmond
- Heart Failure (11 active studies)
- Obesity (11 active studies)
- Breast Cancer (10 active studies)
- Acute Myeloid Leukemia (9 active studies)
- Overweight (8 active studies)
- Malignant Solid Neoplasm (7 active studies)
Leading research sponsors in Richmond
- Virginia Commonwealth University
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- AstraZeneca
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Richmond?
There are approximately 580 recruiting clinical trials in Richmond, Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Richmond pay participants?
Most recruiting trials in Richmond compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Richmond?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Richmond?
The most common conditions under active study in Richmond include Heart Failure (11), Obesity (11), Breast Cancer (10), Acute Myeloid Leukemia (9), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Richmond?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Richmond on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Richmond?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Richmond?
Recruiting research sites in Richmond include Virginia Commonwealth University, VCU Massey Comprehensive Cancer Center, VCU Massey Cancer Center at Stony Point, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Richmond right now?
The largest active categories in Richmond are Cancer & tumors (208), Cardiovascular (43), Diabetes & metabolic (26). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.